• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How TRAIL kills cancer cells, but not normal cells.

作者信息

Gura T

出版信息

Science. 1997 Aug 8;277(5327):768. doi: 10.1126/science.277.5327.768.

DOI:10.1126/science.277.5327.768
PMID:9273698
Abstract
摘要

相似文献

1
How TRAIL kills cancer cells, but not normal cells.
Science. 1997 Aug 8;277(5327):768. doi: 10.1126/science.277.5327.768.
2
Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.原发性B细胞急性淋巴细胞白血病细胞中肿瘤坏死因子（TNF）相关凋亡诱导配体（TRAIL）受体的表达及对TRAIL诱导凋亡的敏感性
Br J Haematol. 2000 Nov;111(2):580-6. doi: 10.1046/j.1365-2141.2000.02404.x.
3
Cell death: TRAIL and its receptors.细胞死亡：肿瘤坏死因子相关凋亡诱导配体及其受体
Curr Biol. 1997 Dec 1;7(12):R750-3. doi: 10.1016/s0960-9822(06)90000-1.
4
Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.人黑色素瘤细胞中肿瘤坏死因子相关凋亡诱导配体（TRAIL）死亡受体与诱饵受体的差异定位及调控
J Immunol. 2000 Apr 15;164(8):3961-70. doi: 10.4049/jimmunol.164.8.3961.
5
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.由一族信号受体和诱饵受体对肿瘤坏死因子相关凋亡诱导配体（TRAIL）诱导的细胞凋亡进行调控。
Science. 1997 Aug 8;277(5327):818-21. doi: 10.1126/science.277.5327.818.
6
Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.抗凋亡蛋白在肿瘤坏死因子相关凋亡诱导配体和顺铂增强凋亡中的作用
Clin Cancer Res. 2003 Aug 1;9(8):3134-41.
7
Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.人中性粒细胞中肿瘤坏死因子相关凋亡诱导配体（TRAIL）及其受体表达的调控
Immunology. 2004 Feb;111(2):186-94. doi: 10.1111/j.0019-2805.2003.01794.x.
8
An antagonist decoy receptor and a death domain-containing receptor for TRAIL.一种TRAIL的拮抗剂诱饵受体和含死亡结构域的受体。
Science. 1997 Aug 8;277(5327):815-8. doi: 10.1126/science.277.5327.815.
9
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm.妊娠足月和早产时人胎膜及羊水中的肿瘤坏死因子相关凋亡诱导配体（TRAIL）、TRAIL受体及可溶性受体骨保护素
J Clin Endocrinol Metab. 2003 Aug;88(8):3835-44. doi: 10.1210/jc.2002-021905.
10
Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.人自身反应性和外源性抗原特异性T细胞中TRAIL受体的表达
Cell Death Differ. 2000 Jul;7(7):637-44. doi: 10.1038/sj.cdd.4400692.

引用本文的文献

1
TRAIL-resistant glioma cells resist Withania somnifera mediated apoptosis via USP5 upregulation.抗TRAIL的胶质瘤细胞通过上调USP5来抵抗睡茄介导的细胞凋亡。
Sci Rep. 2025 Oct 1;15(1):34133. doi: 10.1038/s41598-025-00917-3.
2
Introducing the Potential Binding Interface between the TRAIL-Mimicking Peptide and DR5 via Alanine Scan.通过丙氨酸扫描介绍TRAIL模拟肽与DR5之间的潜在结合界面。
ACS Med Chem Lett. 2025 Apr 25;16(5):829-836. doi: 10.1021/acsmedchemlett.5c00071. eCollection 2025 May 8.
3
Multiple mechanisms contribute to acquired TRAIL resistance in multiple myeloma.
多种机制导致多发性骨髓瘤中获得性TRAIL耐药。
Cancer Cell Int. 2024 Aug 5;24(1):275. doi: 10.1186/s12935-024-03466-3.
4
Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer.针对原发性和脑转移肺癌中细胞死亡和增殖途径的工程化同种异体干细胞的命运和疗效。
Stem Cells Transl Med. 2023 Jul 14;12(7):444-458. doi: 10.1093/stcltm/szad033.
5
Enhancement of Apo2L/TRAIL signaling pathway receptors by the activation of Klotho gene with CRISPR/Cas9 in Caco-2 colon cancer cells.在Caco-2结肠癌细胞中通过CRISPR/Cas9激活Klotho基因增强Apo2L/TRAIL信号通路受体
Med Oncol. 2021 Oct 23;38(12):146. doi: 10.1007/s12032-021-01595-7.
6
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma.肿瘤坏死因子相关凋亡诱导配体（TRAIL）受体在胰腺导管腺癌的恶性细胞和基质细胞中均有表达。
Am J Cancer Res. 2021 Sep 15;11(9):4500-4514. eCollection 2021.
7
Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.调节性 T 细胞衍生的 TRAIL 对于外周耐受不是必需的。
Immunohorizons. 2021 Jan 22;5(1):48-58. doi: 10.4049/immunohorizons.2000098.
8
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.胆碱激酶α功能障碍克服了卵巢癌细胞对 TRAIL 的耐药性。
J Exp Clin Cancer Res. 2021 Jan 4;40(1):5. doi: 10.1186/s13046-020-01794-6.
9
PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR.受miR-429调控的程序性死亡受体配体1（PD-L1）通过表皮生长因子受体（EGFR）结合影响胃癌细胞对肿瘤坏死因子相关凋亡诱导配体（TRAIL）的敏感性。
Front Oncol. 2020 Jul 22;10:1067. doi: 10.3389/fonc.2020.01067. eCollection 2020.
10
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1.miR-221 通过诱导内源性 TRAIL 表达和靶向功能性抑制剂 SOCS3 和 PIK3R1 增强前列腺癌细胞中 TRAIL 介导的细胞凋亡。
Biomed Res Int. 2019 Nov 14;2019:6392748. doi: 10.1155/2019/6392748. eCollection 2019.